IBDEI1V1 ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,33137,1,4,0)
 ;;=4^Q66.51
 ;;^UTILITY(U,$J,358.3,33137,2)
 ;;=^5018867
 ;;^UTILITY(U,$J,358.3,33138,0)
 ;;=M77.32^^191^1965^1
 ;;^UTILITY(U,$J,358.3,33138,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33138,1,3,0)
 ;;=3^Calcaneal Spur,Left Foot
 ;;^UTILITY(U,$J,358.3,33138,1,4,0)
 ;;=4^M77.32
 ;;^UTILITY(U,$J,358.3,33138,2)
 ;;=^5013311
 ;;^UTILITY(U,$J,358.3,33139,0)
 ;;=M77.31^^191^1965^2
 ;;^UTILITY(U,$J,358.3,33139,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33139,1,3,0)
 ;;=3^Calcaneal Spur,Right Foot
 ;;^UTILITY(U,$J,358.3,33139,1,4,0)
 ;;=4^M77.31
 ;;^UTILITY(U,$J,358.3,33139,2)
 ;;=^5013310
 ;;^UTILITY(U,$J,358.3,33140,0)
 ;;=Z48.03^^191^1965^7
 ;;^UTILITY(U,$J,358.3,33140,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33140,1,3,0)
 ;;=3^Change/Removal of Drains
 ;;^UTILITY(U,$J,358.3,33140,1,4,0)
 ;;=4^Z48.03
 ;;^UTILITY(U,$J,358.3,33140,2)
 ;;=^5063036
 ;;^UTILITY(U,$J,358.3,33141,0)
 ;;=E11.51^^191^1966^30
 ;;^UTILITY(U,$J,358.3,33141,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33141,1,3,0)
 ;;=3^DM Type 2 w/ Diab Periph Angiopath w/o Gangrene
 ;;^UTILITY(U,$J,358.3,33141,1,4,0)
 ;;=4^E11.51
 ;;^UTILITY(U,$J,358.3,33141,2)
 ;;=^5002650
 ;;^UTILITY(U,$J,358.3,33142,0)
 ;;=E11.52^^191^1966^29
 ;;^UTILITY(U,$J,358.3,33142,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33142,1,3,0)
 ;;=3^DM Type 2 w/ Diab Periph Angiopath w/ Gangrene
 ;;^UTILITY(U,$J,358.3,33142,1,4,0)
 ;;=4^E11.52
 ;;^UTILITY(U,$J,358.3,33142,2)
 ;;=^5002651
 ;;^UTILITY(U,$J,358.3,33143,0)
 ;;=E11.59^^191^1966^18
 ;;^UTILITY(U,$J,358.3,33143,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33143,1,3,0)
 ;;=3^DM Type 2 w/ Circulatory Compl NEC
 ;;^UTILITY(U,$J,358.3,33143,1,4,0)
 ;;=4^E11.59
 ;;^UTILITY(U,$J,358.3,33143,2)
 ;;=^5002652
 ;;^UTILITY(U,$J,358.3,33144,0)
 ;;=E11.610^^191^1966^27
 ;;^UTILITY(U,$J,358.3,33144,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33144,1,3,0)
 ;;=3^DM Type 2 w/ Diab Neuropath Arthropathy
 ;;^UTILITY(U,$J,358.3,33144,1,4,0)
 ;;=4^E11.610
 ;;^UTILITY(U,$J,358.3,33144,2)
 ;;=^5002653
 ;;^UTILITY(U,$J,358.3,33145,0)
 ;;=E11.618^^191^1966^22
 ;;^UTILITY(U,$J,358.3,33145,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33145,1,3,0)
 ;;=3^DM Type 2 w/ Diab Arthropathy NEC
 ;;^UTILITY(U,$J,358.3,33145,1,4,0)
 ;;=4^E11.618
 ;;^UTILITY(U,$J,358.3,33145,2)
 ;;=^5002654
 ;;^UTILITY(U,$J,358.3,33146,0)
 ;;=E11.620^^191^1966^24
 ;;^UTILITY(U,$J,358.3,33146,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33146,1,3,0)
 ;;=3^DM Type 2 w/ Diab Dermatitis
 ;;^UTILITY(U,$J,358.3,33146,1,4,0)
 ;;=4^E11.620
 ;;^UTILITY(U,$J,358.3,33146,2)
 ;;=^5002655
 ;;^UTILITY(U,$J,358.3,33147,0)
 ;;=E11.622^^191^1966^34
 ;;^UTILITY(U,$J,358.3,33147,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33147,1,3,0)
 ;;=3^DM Type 2 w/ Skin Ulcer NEC
 ;;^UTILITY(U,$J,358.3,33147,1,4,0)
 ;;=4^E11.622
 ;;^UTILITY(U,$J,358.3,33147,2)
 ;;=^5002657
 ;;^UTILITY(U,$J,358.3,33148,0)
 ;;=E11.628^^191^1966^33
 ;;^UTILITY(U,$J,358.3,33148,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33148,1,3,0)
 ;;=3^DM Type 2 w/ Skin Compl NEC
 ;;^UTILITY(U,$J,358.3,33148,1,4,0)
 ;;=4^E11.628
 ;;^UTILITY(U,$J,358.3,33148,2)
 ;;=^5002658
 ;;^UTILITY(U,$J,358.3,33149,0)
 ;;=E11.69^^191^1966^19
 ;;^UTILITY(U,$J,358.3,33149,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33149,1,3,0)
 ;;=3^DM Type 2 w/ Complications NEC
 ;;^UTILITY(U,$J,358.3,33149,1,4,0)
 ;;=4^E11.69
 ;;^UTILITY(U,$J,358.3,33149,2)
 ;;=^5002664
 ;;^UTILITY(U,$J,358.3,33150,0)
 ;;=E11.8^^191^1966^20
 ;;^UTILITY(U,$J,358.3,33150,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33150,1,3,0)
 ;;=3^DM Type 2 w/ Complications,Unspec
